SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-017761
Filing Date
2012-01-20
Accepted
2012-01-20 08:01:07
Documents
7
Period of Report
2012-01-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d284844d8k.htm 8-K 57609
2 EXHIBIT 2.1 d284844dex21.htm EX-2.1 140149
3 EXHIBIT 3.1 d284844dex31.htm EX-3.1 153361
4 EXHIBIT 10.1 d284844dex101.htm EX-10.1 209528
5 EXHIBIT 10.2 d284844dex102.htm EX-10.2 24590
6 EXHIBIT 10.3 d284844dex103.htm EX-10.3 24404
7 EXHIBIT 10.4 d284844dex104.htm EX-10.4 14512
  Complete submission text file 0001193125-12-017761.txt   625774
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 12535848
SIC: 2836 Biological Products, (No Diagnostic Substances)